With over 20 years of experience as a radiation oncologist, Dr Patrick Bowden is a leading expert in the field of advanced radiation therapy. He obtained his medical degree from the University of Melbourne in 1994. His oncology career began at the prestigious Peter MacCallum Cancer Centre, where he became Director of the Tattersall’s Cancer Centre. Dr Bowden has been instrumental in building some of the nation’s most advanced radiotherapy services, including his role as the inaugural Director of Epworth Radiation Oncology, where he established Australia’s largest stereotactic radiation therapy service.
Dr Bowden’s expertise is not just clinical but also academic. He has been the principal investigator in numerous groundbreaking clinical trials, including the TRANSFORM study, which evaluated the efficacy of stereotactic radiation therapy for oligometastatic prostate cancer. This was the largest trial ever conducted in the world on this disease. His work continues to shape the future of radiation oncology, with a focus on improving patient outcomes and advancing cancer care.
Dr Paul Conway is a rising star in radiation oncology, providing compassionate, patient-centred care, combining advanced techniques and technology to offer the highest quality of treatment available. He completed his general medical training (MBBS) graduating with First Class Honours in 2013. Dr Conway then undertook specialty Radiation Oncology training becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2021. He has received further sub-speciality training during a two year fellowship under Dr Pat Bowden, focussing on advanced techniques including stereotactic radiotherapy in the management of urologic and metastatic disease. Dr Conway now collaborates with Dr Bowden, leveraging their combined expertise to benefit patients.
Dr Conway is committed to staying at the forefront of radiation oncology, actively participating in research and clinical trials, particularly in the area of stereotactic radiotherapy for early stage primary cancers and oligometastatic disease. His work is guided by a belief in empowering patients with evidence-based information and personalised treatment plans, ensuring that every patient feels confident and supported throughout their treatment journey.
Our team’s extensive experience in radiation oncology, combined with state-of-the-art technology, ensures that our patients receive the most effective treatment available.